Todas as matérias desta seção, das mais recentes às mais antigas — página 28 de 371.
Dot Ai (NASDAQ:DAIC) completed the acquisition of Envoy Technologies from BladeRanger through an all-stock transaction valued at approximately $65 million, using common stock and Series C Convertible Preferred Stock based on an agreed $6 reference price.
Flyte Aviation (NASDAQ:VJET) reported preliminary third-quarter 2026 revenue of approximately $2.15 million, compared with $1.02 million in the second quarter of 2026.
Enovix (NASDAQ:ENVX) reported preliminary Q3 2026 revenue of approximately $11 million, compared with company guidance of $9 million to $10 million, while revenue increased from the prior-year period.
Bristol Myers Squibb (NYSE:BMY) announced topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ101 (225Ac-DOTATATE) in patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Tracks Biotherapeutics (NASDAQ:TRAX) reported Phase 1b results for ANB033, showing statistically significant changes in intestinal damage and immune-cell measurements during a gluten-challenge study in patients with celiac disease.
Kratos Defense & Security Solutions (NASDAQ:KTOS) and Airbus completed the first European test flight of the U740-Valkyrie uncrewed combat aircraft, with the flight meeting planned objectives including autonomous flight operations and mission adjustments.
Bristol Myers Squibb (NYSE:BMY) announced topline results from the Phase 3 ALOFT-IPF trial, where admilparant demonstrated a statistically significant improvement in absolute change in forced vital capacity (FVC) from baseline to Week 52 compared with placebo at the 60 mg dose.
Lazard (NYSE:LAZ) reported preliminary unaudited assets under management of $284,029 million as of September 30, 2026, compared with $290,332 million on August 31, 2026.
Cable One (NYSE:CABO) said the U.S. District Court for the Southern District of New York entered a temporary restraining order on October 9, 2026, blocking the company from completing the purchase of the 55% of Mega Broadband Investments Holdings LLC (MBI) that it does not currently own.
DHT Holdings (NYSE:DHT) estimated third-quarter 2026 fleet time charter equivalent earnings at $141,300 per day, based on 2,055 revenue days including 1,054 spot market days.
ASE Technology Holding (NYSE:ASX) reported unaudited September 2026 consolidated net revenues of NT$88,130 million, with revenue increasing compared with both August 2026 and September 2025.
Nokia (NYSE:NOK) introduced a new fiber-broadband line card that supports GPON, 10G, 25G and 50G PON technologies on every port, giving operators flexibility in selecting network configurations.
TotalEnergies (NYSE:TTE) and KKR (NYSE:KKR) signed an agreement to add 700 MW of utility-scale solar capacity to their 50/50 U.S. joint venture created in 2025, which currently owns 1.4 GW of assets.
Sysco (NYSE:SYY) said it has agreed on economic terms with Teamsters Locals 630 and 848 but has not completed a final Los Angeles labor agreement, leaving the strike ongoing.
Scage Future (NASDAQ:SCAG) reported cumulative deliveries of 203 vehicles, with fiscal 2026 deliveries including 78 autonomous port tractors and 40 Galaxy II trucks as the company provided operating updates and compliance information.
Oil prices moved higher on Monday as traders weighed potential additional supplies against renewed geopolitical risks affecting Middle East energy infrastructure.
Strategy (NASDAQ:MSTR) acquired 250 Bitcoin during the week of October 5 to October 11, 2026, while also repurchasing 1,932,145 shares of its STRC preferred stock for $192.4 million.
Toro (NASDAQ:TORO) reported second-quarter net income of $0.6 million, down 60.9% from the same period in 2025.
Gorilla Technology Group (NASDAQ:GRRR) signed a non-binding letter of intent to acquire its first U.S. data center, with completion targeted by the end of November 2026.
Sagimet Biosciences (NASDAQ:SGMT) reported 52-week denifanstat acne results from license partner Ascletis’ Phase 3 extension study, including 57% Investigator’s Global Assessment success.
Profound Medical (NASDAQ:PROF) entered a co-education agreement with Telix Pharmaceuticals to support physician education on imaging-informed prostate care.
Arcutis Biotherapeutics (NASDAQ:ARQT) presented new ZORYVE clinical data in infants with atopic dermatitis and patients with psoriasis at EADV and Fall Clinical.
Teva Pharmaceutical Industries (NYSE:TEVA) received U.S. Food and Drug Administration approval for WELTRUZA, a once-monthly subcutaneous olanzapine injection for adults with schizophrenia.
Valion Bio (NASDAQ:VBIO) and Shear Kershman Laboratories completed formulation work on an oral mucosal version of Entolimod for potential use in radiation emergencies.
